BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 14, 2013
View Archived Issues
Evaluation of an inhalable gene therapy for the treatment of PAH
Read More
Researchers at AiCuris synthesize new monobactam derivatives for bacterial infections
Read More
Team of researchers at Galecto Biotech patents novel galectin inhibitors
Read More
Researchers present phase III results for 99mTc tilmanocept in melanoma patients
Read More
Cellceutix to initiate Prurisol clinical trial
Read More
Zebrafish model mimics human affective disorders
Read More
Phase II trial finds fluorescein an alternative for SLN identification in melanoma
Read More
FDA approves ViiV Healthcare's Tivicay for treatment of HIV-1
Read More
Identification of a rare genetic deletion with the development of neurodevelopmental disorders
Read More
Amarantus reports encouraging preclinical data for MANF in retinitis pigmentosa
Read More
MatinasBioPharma receives financing for omega-3 candidate
Read More
Cystinosis Research Foundation issues six grants in the U.S. and Canada
Read More
U.K.'s MRC supports Cyclacel's seliciclib study in RA
Read More
Novel KLB1 inhibitors disclosed by Novartis
Read More
Chinese group presents novel agents for cancer and other disorders
Read More
Shenogen Pharma Group synthesizes novel agents for cancer
Read More
Vifor Pharma and Zeria Pharmaceutical enter licensing agreement for Ferinject
Read More
Canadian government provides funding to expand HIV antibody program
Read More
Lundbeck divulges novel PDE9 inhibitors for neurodegenerative disorders
Read More
Sunovion Pharmaceuticals and Afraxis form drug discovery partnership
Read More
ImmuPharma provides update on IPP-204106 cancer program
Read More
Methoxyflurane trial meets primary and secondary endpoints
Read More
MM-111 receives FDA orphan drug status for gastric and esophageal cancers
Read More
Hanmi gains U.S. approval for incrementally modified drug Esomezol
Read More
Thomson Reuters, PathGroup and GenoSpace collaborate on personalized oncology medicine service
Read More